Publications by authors named "Anthony Hunter"

Claim this Profile
E
Expert consensus definition of treatment intolerance in chronic myeloid leukemia in chronic phase.
Ehab Atallah, Michael S Broder, Onyee Chan, Kathryn E Flynn, Jeffrey A Gilreath, Anthony M Hunter

Hematology· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world analysis of polycythemia vera treatment reveals nonadherence to NCCN guidelines in a large proportion of patients.
Ghaith Abu-Zeinah, Anthony M Hunter, Joseph J Shatzel, Abdulraheem Yacoub, Albert Qin

Blood Neoplasia· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Emerging Significance and Implications of a Durable Complete Molecular Remission in the Treatment of Polycythemia Vera.
Minghui Duan, Prithviraj Bose, Anthony M Hunter, Albert Qin, Long Chang

Curr Hematol Malig Rep· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A pharmacovigilance study of adverse events associated with polycythemia vera treatments using the FDA Adverse Event Reporting System (FAERS) database.
Brandi N Reeves, Lucia Masarova, Ghaith Abu-Zeinah, Anthony M Hunter, Joseph J Shatzel

Ann Hematol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk factors, behaviors, and adverse health outcomes of financial toxicity in adult chronic myeloid leukemia survivors: a theory-based structural equation model.
Ruiqi Jin, Sudeshna Paul, Sarah M Belcher, Jinbing Bai, Ilana Graetz, Anthony M Hunter

Support Care Cancer· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SOHO State of the Art Updates and Next Questions | Choosing and Properly Using a JAK Inhibitor in Myelofibrosis.
Michael J Hochman, Colin A Vale, Anthony M Hunter

Clin Lymphoma Myeloma Leuk· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A multicenter study to assess efficacy, safety, and tolerability of ropeginterferon alfa-2b-njft in patients with essential thrombocythemia in the US and Canada: EXCEED-ET trial.
Lucia Masarova, Brandi N Reeves, Firas El Chaer, Lynda Foltz, Tsewang Tashi, Anthony M Hunter

Front Med (Lausanne)· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Olverembatinib After Failure of Tyrosine Kinase Inhibitors, Including Ponatinib or Asciminib: A Phase 1b Randomized Clinical Trial.
Elias Jabbour, Vivian G Oehler, Paul B Koller, Omer Jamy, Elza Lomaia, Anthony M Hunter

JAMA Oncol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Perspectives on drug development in chronic myelomonocytic leukemia: changing the paradigm.
Anthony M Hunter, Mrinal M Patnaik, Raphael Itzykson, Ruben Mesa, Chatchada Karanes

Blood· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advances with janus kinase inhibitors for the treatment of myeloproliferative neoplasms: an update of the literature.
Anthony M Hunter, Prithviraj Bose

Expert Opin Pharmacother· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Automated tabulation of clinical trial results: A joint entity and relation extraction approach with transformer-based language representations.
Jetsun Whitton, Anthony Hunter

Artif Intell Med· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Progenitor Hierarchy of Chronic Myelomonocytic Leukemia Identifies Inflammatory Monocytic-Biased Trajectory Linked to Worse Outcomes.
Meghan C Ferrall-Fairbanks, Abhishek Dhawan, Brian Johnson, Hannah Newman, Virginia Volpe, Anthony M Hunter

Blood Cancer Discov· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating complete remission with partial hematologic recovery (CRh) as a response criterion in myelodysplastic syndromes (MDS).
Andrew M Brunner, Alexander Gavralidis, Najla Al Ali, Anthony Hunter, Rami Komrokji

Blood Cancer J· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differential prognostic impact of IDH1 and IDH2 mutations in chronic myelomonocytic leukemia.
Connor Walsh, Anthony Hunter, Terra Lasho, Christy Finke, Rhett Ketterling

Leukemia· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Marrow ring sideroblasts are highly predictive for TP53 mutation in MDS with excess blasts.
David M Swoboda, Rashmi Kanagal-Shamanna, Andrew M Brunner, Thomas Cluzeau, Onyee Chan, Anthony M Hunter

Leukemia· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Asxl1 loss cooperates with oncogenic Nras in mice to reprogram the immune microenvironment and drive leukemic transformation.
Xiaona You, Fabao Liu, Moritz Binder, Alexis Vedder, Terra Lasho, Anthony M Hunter

Blood· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrated Human and Murine Clinical Study Establishes Clinical Efficacy of Ruxolitinib in Chronic Myelomonocytic Leukemia.
Anthony M Hunter, Hannah Newman, Amy E Dezern, David P Steensma, Sandrine Niyongere

Clin Cancer Res· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Leukocytosis is associated with end organ damage and mortality in chronic myelomonocytic leukemia and can be mitigated by cytoreductive therapy.
Anthony M Hunter, Najla Al Ali, Anne Mai, Savan Shah, David M Swoboda

Leuk Res· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genomic Landscape and Risk Stratification in Chronic Myelomonocytic Leukemia.
Anthony Hunter, Eric Padron

Curr Hematol Malig Rep· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evolutionary action score identifies a subset of TP53 mutated myelodysplastic syndrome with favorable prognosis.
Rashmi Kanagal-Shamanna, Guillermo Montalban-Bravo, Panagiotis Katsonis, Koji Sasaki, Caleb A Class, Anthony Michael Hunter

Blood Cancer J· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of patients with chronic myelomonocytic leukaemia treated with non-curative therapies: a retrospective cohort study.
Lisa Pleyer, Michael Leisch, Alexandra Kourakli, Eric Padron, Jaroslaw Pawel Maciejewski, Anthony Michael Hunter

Lancet Haematol· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Baseline and serial molecular profiling predicts outcomes with hypomethylating agents in myelodysplastic syndromes.
Anthony M Hunter, Rami S Komrokji, Seongseok Yun, Najla Al Ali, Onyee Chan

Blood Adv· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular genetics of MDS/MPN overlap syndromes.
Anthony M Hunter, Eric Padron

Best Pract Res Clin Haematol· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical, molecular, and prognostic correlates of number, type, and functional localization of TET2 mutations in chronic myelomonocytic leukemia (CMML)-a study of 1084 patients.
Giacomo Coltro, Abhishek A Mangaonkar, Terra L Lasho, Christy M Finke, Prateek Pophali, Anthony Hunter

Leukemia· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting TP53 Mutations in Myelodysplastic Syndromes.
Anthony M Hunter, David A Sallman

Hematol Oncol Clin North Am· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis